Alnylam Pharmaceuticals
ALNY
#692
Rank
C$52.45 B
Marketcap
C$392.90
Share price
-2.49%
Change (1 day)
-6.26%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company